POAI (Predictive Oncology) Gross Profit Margin

POAI (predictive-oncology.com) - company brandmark

Geopolitical risks and data exchange restrictions are hindering the expansion of Predictive Oncology (POAI). The net gross margin reflects current dynamics, with the value fixed at -19.30. The business relies on AI-driven modeling of tumor responses and the volume of clinical databases. High retention is ensured by integration into the R&D of pharma behemoths and support from the FDA regarding preclinical testing.

POAI - predictive-oncology.com Return on Gross Profit over the range 07/04/2022 - 12/12/2025

Analytical breakdowns and data insights for company Predictive Oncology Inc. (POAI)

Basic company analysis:Predictive Oncology (POAI)
Mass-produced product of predictive-oncology.com

Gross margin determines capital resilience to market shocks by measuring the share of profit after deducting direct production costs. The high technological barrier of Predictive Oncology (POAI), driven by proprietary algorithms and unique biodata, creates a foundation for high profitability, which is reflected in the gross income metric, helping investors assess the efficiency of intellectual property monetization and the risk of overpaying for the asset.

Direct competitors

Return on Gross Profit Intuitive|Gross Profitability Danaher Corp.|Gross Return on Sales BDX (Becton Dickinson & Co)|Return on Gross Profit STE (STERIS Corporation)|Gross Profit Ratio WST|Gross Profitability Baxter International Inc. BAX|Gross Profit Ratio MASI (Masimo Corp)|STVN - Gross Profitability|Teleflex Inc - Gross Profit Ratio|merit.com (MMSI) - Gross Profitability|Gross Profit Margin envistaco.com (NVST)|ICUI (ICU Medical Inc) - Gross Margin|Gross Profit Margin Dentsply Sirona Inc XRAY|Gross Profitability LeMaitre Corp (LMAT)|ATRC (AtriCure Corp) - Gross Profit Rate|Gross Margin STAA (STAAR Surgical Co)|ChromaDex Corporation (NAGE) - Gross Profit Margin|ZimVie Inc - Gross Margin|Gross Profit Margin AngioDynamics|CERS (Cerus Corp) - Return on Gross Profit|Alpha Teknova, Inc. - Gross Profit Rate|MGRM (Monogram Orthopedics Inc.) - Gross Margin|STSS: Gross Profit Rate|Return on Gross Profit INFU (InfuSystem Holdings)|Utah Medical Products, Inc. - Gross Return on Sales|Gross Margin KRMD (korumedical.com)|Return on Sales by Gross Profit Nyxoah, S.A. (NYXH)|MBOT - Gross Profitability|PDEX (Pro-Dex, Inc.) - Gross Return on Sales|ZTEK (Zentek Ltd) - Return on Gross Profit|ELUT - Return on Sales by Gross Profit|MLSS (Milestone Scientific Corporation) - Gross Margin|Gross Return on Sales NXGL (NEXGEL, Inc.)|Gross Margin RVP|Return on Gross Profit Harvard Bioscience HBIO|Gross Margin FEMY (Femasys Corporation)|MHUA - Return on Gross Profit|Callan JMB - Gross Margin|Atrion Corp - Gross Profit Ratio|NURO (neurometrix.com) - Return on Gross Profit